Ledipasvir 33.75 mg / sofosbuvir 150 mg per packet Oral Pellets
RxNorm 2204100 NDC Crossover

The following National Drug Codes (NDCs) are directly associated with the clinical concept for Ledipasvir 33.75 mg / sofosbuvir 150 mg per packet Oral Pellets (RxCUI 2204100). This crossover tool provides a verified mapping between standardized RxNorm clinical drug definitions and the specific manufactured products listed in the FDA NDC directory.

Healthcare professionals, pharmacists, and data analysts use this list to identify various brand names, labelers, and commercial packaging variations linked to this semantic clinical drug concept. Each entry below represents a commercial product that fulfills the requirements of this specific clinical identifier.